baber/WOPTO huggingface dataset:
Patent NZ-235189-A (NZ)
Title: Pole mounted cylindrical display device assembled from two identical mouldings having engaging male and female rim members
Inventor: POWER PETER ANDREW
IPC: G09F11/02
Filed: 1990-09-05
Abstract: A display device comprises a cylindrical drum 10 which is manufactured from two identical mouldings 11 and rotatably mounted on two nylon bearings 14 each of which is secured to post A. One moulding 11 is orientatable in a frist direction and a second moulding 11 is orientatable in a second opposite direction so as to enable the mouldings to engage. The male rim section 50 of one moulding 11 engages in the female rim section 60 of the second moulding. Each side of the female rim section 60 has ten supporting lugs 70 which support the male rim section 50 of the other moulding when engaged.
Patent NZ-237151-A (NZ)
Title: N-phenyl-n-alkoxycarbonylalkyl glycinamides, their preparation and the medicaments containing them
Inventor: BOURZAT JEAN-DOMINIQUE
IPC: A61P25/00
Filed: 1991-02-19
Abstract: PCT No. PCT/FR91/00119 Sec. 371 Date Jun. 25, 1992 Sec. 102(e) Date Jun. 25, 1992 PCT Filed Feb. 14, 1991 PCT Pub. No. WO91/12265 PCT Pub. Date Aug. 22, 1991.This invention relates to compounds of formula:    <IMAGE>  (I)  in which R1 represents a hydrogen atom or an alkyl or alkoxycarbonyl radical or an unsubstituted or substituted phenyl radical, R2 represents an alkyl (1-8 C) or polyfluoroalkyl radical or an unsubstituted or substituted cycloalkyl radical, R3 represents an unsubstituted or substituted phenyl radical, a naphthyl, indolyl, quinolyl or phenylamino radical in which the phenyl ring is optionally substituted, or a quinolylamino radical, and m is 0 or 1, the process for preparing them and the medicaments containing them.
Patent NZ-238533-A (NZ)
Title: Specific dna targeting sequence that directs the associated gene product into a plant vacuole
Inventor: BOLLER THOMAS
IPC: C12N15/29
Filed: 1991-06-13
Abstract: The present invention relates to peptide fragments [targeting signal] which can be obtained from the terminal region [C-terminal extension] of plant vacuole proteins and which, operably linked to any desired protein molecule, ensure targeted introduction of the proteins associated with the peptide fragments into the plant vacuoles, and to the DNA molecules coding for said peptide fragments. The present invention further relates to recombinant DNA molecules which contain a DNA sequence according to the invention operably linked to an expressible DNA, and to the vectors derived therefrom. Likewise embraced are host cells and/or host organisms including transgenic plants which contain said recombinant DNA or the vectors derived therefrom.
Patent NZ-258982-A (NZ)
Title: Trisubstituted benzene derivatives having at least one alkoxy or halogen substituent and at least one (cyclo)alk(en)ylated hydroxy, mercapto or amino group
Inventor: WARRELLOW GRAHAM JOHN
IPC: C07B57/00
Filed: 1993-12-22
Abstract: Compounds of general formula (1) are described wherein Y is a halogen atom or a group -OR<1>, where R<1> is an optionally substituted alkyl group; X is -O-, -S- or -N(R<8>)-, where R<8> is a hydrogen atom or an alkyl group; R<2> is an optionally substituted alkyl, alkenyl, cycloalkyl or cycloalkenyl group; R<3> is a hydrogen or halogen atom or an -OR<9> group, where R<9> is a hydrogen atom or an optionally substituted alkyl, alkenyl, alkoxyalkyl, or alkanoyl group, or a formyl, carboxamido or thiocarboxamido group; R<4> and R<5>, which may be the same or different, is each a group (CH2)nAr, where Ar is a monocyclic or bicyclic aryl group optionally containing one ore more heteroatoms selected from oxygen, sulphur or nitrogen atoms and n is zero or an integer 1, 2 or 3; R<6> is a hydrogen atom or an optionally substituted alkyl group; R<7> is a hydrogen atom or an optionally substituted alkyl group; and the salts, solvates, hydrates and N-oxides thereof. Compounds according to the invention are potent, selective and orally active PDE IV inhibitors and are useful in the prophylaxis and treatment of asthma and other diseases. <IMAGE>
Patent NZ-306310-A (NZ)
Title: Spirocyclic and bicyclic diazinyl and carbazinyl oxazolidinones
Inventor: BARBACHYN MICHAEL ROBERT
IPC: A61K31/435
Filed: 1996-04-18
Abstract: Spirocyclic and fused bicyclic diazinyl and carbazinyl oxazolidinone compounds of structural Formula (I or II), or the pharmaceutically acceptable salts of these compounds, are useful for treating microbial infections in humans or other warm-blooded animals.  R3 is preferably H or F, R4 is most preferably methyl, R5 is preferably hydroxyacetal.
Patent NZ-314792-A (NZ)
Title: Sanitary napkin comprises stack of separate absorbent pads peelably united at periphery
Inventor: YAMADA IKUKO
IPC: A61F13/15
Filed: 1997-05-12
Abstract: A multi-layer sanitary napkin (10) comprising a plurality of ordinary sanitary napkins (1) for menses or leukorrhea which are supplied in a single-use form, each being provided with an absorbing surface and a rim, wherein the ordinary napkins are piled with respective absorbing surfaces thereof directed upward, and peelably joined with each other into unity at the rims by bonding, embossing or simultaneous bonding and embossing. Each of the ordinary napkins contained therein can be shaped as concave as a ship's bottom, to shape the entire figure of the multi-layer sanitary napkin in the same manner. The multi-layer sanitary napkin can further comprise pull tabs (3) formed on either end of respective ordinary napkins, each tab being formed not so as to overlap on neighboring ones. <IMAGE>
Patent NZ-318818-A (NZ)
Title: The use of compounds that are able to bind to the non-coding regions of a gene in the manufacture of a medicament for suppressing the expression of an endogenous gene
Inventor: FARRAR GWENYTH JANE
IPC: C07K14/47
Filed: 1996-09-23
Abstract: The use of suppression effectors able to bind to the non-coding regions of a gene to be suppressed in the manufacture of a medicament for the prevention of the functional expression of an endogenous gene. The suppression effectors may be antisense nucleic acids, and the non-coding regions can include the transcribed but non-translated regions of a gene. A replacement gene can also be introduced.
Patent NZ-325014-A (NZ)
Title: amino-alkylene substituted indole derivatives which are antagonists of gonadotropin releasing hormone
Inventor: GOULET MARK
IPC: A61P13/00
Filed: 1996-12-10
Abstract: The indole derivatives have the formula I wherein: A is alkoxy, C0-5 alkyl-S(O)n-C0-5 alkyl, C0-5 alkyl-O-C0-5 alkyl, C0-5 alkyl-N(R18)-C0-5 alkyl or optionally substituted alkyl, cycloalkyl, alkenyl or alkynyl or is -C(R16)=N-(CH2)p- or a single bond; R0 is H, optionally substituted alkyl, aryl or aralkyl; R1 is nitrogen containing heterocyclic ring system as defined in the specification such as benzofuran, indole, pyridyl, benzimidazole, tetrazolyl, furan or thiazolyl; R2 is H, optionally substituted alkyl, aryl or aralkyl or is alkyl-OR11, alkyl-NR11R12, alkyl-CONR11R12, or C(NR11R12)NH or R2 and A together can form a ring of 5-7 atoms; R3, R4 and R5 are independently H, CN, nitro, perfluoroalkyl, perfluoroalkoxy, R11O-(CH2)p-, R11C(O)O-(CH2)p-, R11OC(O)-(CH2)p-, -(CH2)p-S(O)n-R17, -(CH2)p-C(O)-NR11R12 or halogen or are optionally substituted alkyl, alkenyl, alkynyl, aryl or aralkyl or R3 and R4 taken together can form a carbocyclic ring of 3-7 carbon atoms or a heterocyclic ring containing 1-3 heteroatoms of N, O or S; R6 is H, optionally substituted alkyl or aryl, perfluoroalkyl, CN, NO2, halo, R11O-(CH2)p-, NR12C(O)R11, NR12C(O)NR11R12 or -S(O)nR11; R7 is H or optionally substituted alkyl unless X is H or halo then R7 is absent; R8 is C(O)OR9, C(O)NR11R12, NR11R12, C(O)R11, NR12C(O)R11, NR12C(O)NR11R12, NR12-S(O)2R12, NR12S(O)2NR11R12, OC(O)R11, OC(O)NR11R12, OR11, S(O)nR11, S(O)nNR11R12 or  optionally substituted alkyl unless X is H or halogen, then R8 is absent or R7 and R8 taken together form a carbocyclic ring of 3-7 ring atoms; R9 and R9a are independently H, optionally substituted alkyl, aralkyl or aryl when m is not 0 or are taken together to form a carbocyclic ring of 3-7 atoms or =O when m is not 0 or R9 and A are taken together to form a  heterocyclic ring containing 3-7 carbons and one or more heteroatoms when m is not 0 or R10 and R10a are independently H, optionally substituted alkyl, aralkyl or aryl or are taken together to form a carbocyclic ring of 3-7 atoms or =O or R9 and R10 are taken together to form a carbocyclic ring of 3-7 carbons or a heterocyclic ring containing one or more heteroatoms when m is not 0 or R9 and R2 are taken together to form a heterocyclic ring of 3-7 carbons and one or more heteroatoms when m is not 0 or R10 and R2 are taken together to form a heterocyclic ring of 3-7 carbons and one or more heteroatoms or R10 and A are taken together to form a heterocyclic ring of 3-7 carbons and one or more heteroatoms and the rest of the variables are as defined in the specification. A pharmaceutical composition thereof is useful in the treatment of sex hormone dependent cancer or condition, benign prostatic hypertrophy or myoma of the uterus.
Patent NZ-331772-A (NZ)
Title: Device for highly sensitive magnetic detection of analytes with receptor ligand binding
Inventor: KOCH HANS
IPC: G01N33/553
Filed: 1997-03-26
Abstract: An apparatus for the qualitative and/or quantitative measurement of analytes, in both biological and non-biological test samples 12, by means of ligand-receptor bonds, uses a magnetizing device 11 for producing a magnetic field at the site of the test sample, and a detection device 71, 8, 9, 10 for measuring magnetic properties of the test sample. The magnetizing device is spatially arranged with respect to the detection device so that the magnetic field produced by the magnetizing device at the site which the test sample occupies during measurement is attenuated by at least a factor of 10 and preferably by a factor of 1000 or more. Alternatively, a switching device is provided which can turn off the magnetic field of the magnetizing device at the site of the test sample for a pre-set period during, and preferably for the duration of, the measurement phase of the detection device. The apparatus is suitable for magneto-relaxometric detection of analytes and for detection of analytes by means of remanence measurement, routinely and economically in vitro or in vivo.
Patent NZ-333357-A (NZ)
Title: Reduction of cardiotoxicity of an antitumor agent using manganese compound
Inventor: TOWART ROBERTSON
IPC: A61K33/32
Filed: 1997-06-24
Abstract: A physiologically tolerable manganese chelate or a salt thereof is used in the manufacture of a medicament for use in reducing the cardiotoxicity of an anti-tumour agent. The chelate has a Ka range of 109 to 1025 and the anti-tumour agent can be doxorubicin or daunomycin.
Patent NZ-334828-A (NZ)
Title: Contains no O-acetyl groups detectable by NMR and binds to antibodies to S.aureus further conjugated with Pseudomonas aeruginosa exotoxin A as an immunocarrier to detect S.aureus infection
Inventor: FATTOM ALI IBRAHIM
IPC: G01N33/569
Filed: 1997-09-11
Abstract: A negatively-charged S. aureus antigen contains beta-hexosamine as a major carbohydrate component S. aureus strains that carry the antigen account for nearly all of the clinically significant strains of S. aureus that are not Type 5 or Type 8 strains. The antigen can be used in combination with S. aureus Type 5 polysaccharide antigen and S. aureus Type 8 polysaccharide antigen to provide nearly 100% coverage of S. aureus infection.
Patent NZ-335032-A (NZ)
Title: Agricultural apparatus and methods with superheated steam to fumigate soils and plants, weed soils, defoliate plants and dry fruits in situ
Inventor: BROWN CLAUDE E
IPC: A01G17/02
Filed: 1998-01-14
Abstract: An apparatus, useful for agricultural applications, comprises: a) a portable frame; b) a water reservoir mounted on the frame which defines an upstream end of a fluid passageway carried by the frame; c) a first chamber disposed along the fluid passageway downstream of the reservoir which includes a heater operable to convert water flowed from the reservoir and through the chamber into steam; d) a second chamber disposed along the fluid passageway which is constructed to be sufficient to receive steam at a first temperature range downstream of the first chamber and to heat the received steam to a second temperature range, wherein the steam at the second temperature range is superheated ; e) a steam separator disposed along the fluid pathway and being between the first and second chambers which is able of separating liquid from the steam flowing in the passageway and f) an outlet adapted to deliver a flow of superheated steam from the second chamber. Methods for treating plants and fields in agricultural applications using the above apparatus to selectively deliver superheated steam to adjacent to grape vine leaves in order to defoliate basal leaves and to kill localized insect pests or injecting superheated steam in strawberry beds prior to planting to kill nematodes are disclosed. The superheated steam is delivered at temperatures in excess of about 300oF.
Patent NZ-500247-A (NZ)
Title: Propagation substrate having non-compressed sphagnum moss and non-toxic resin binder
Inventor: FROGLEY CHRISTOPHER JOHN
IPC: A01G9/10
Filed: 1999-10-12
Abstract: A growing medium comprising a self-supporting block formed from sphagnum material bound together by a binding material, such as an ethylene vinyl acetate (EVA) adhesive, dispersed through a sphagnum material is described.  The growing medium may also include fibrous material such as carded wool and cellulose fibres (paper pulp).  The binding material is made in the form of an aqueous dispersion and is mixed with the sphagnum to form a slurry.  After drying, the growing material can be moulded and/or cut into any required shape. Fig 1 shows a single block (2) of growing medium in which the major portion of the block is formed from the base component (4) but with an exterior coating (3) applied around the base and sides of the block (2).  The block is formed with aperture (5) for the insertion of a single seedling or cutting.
Patent NZ-503364-A (NZ)
Title: Tunable optical filter, active doped optical fibre with long period Bragg grating
Inventor: VAVASSORI PAOLO
IPC: H04B10/12
Filed: 2000-03-14
Abstract: An optical transmission system includes a doped optical fibre 4, the dopant being capable of being excited by a source 6.  The doped fibre includes a Bragg grating 5, the grating being a long period grating.  The excitation source is coupled to the fibre by coupler 7.  The coupler may be a WDM coupler.   The Bragg grating in this case acts as a tunable optical filter.
Patent NZ-505976-A (NZ)
Title: Particle transporter chucks using repulsive field guidance
Inventor: SUN HOI C
IPC: B01L99/00
Filed: 1999-02-19
Abstract: Bead  transporter  chucks for selective  pick  up  and discharging  of  polymer  beads for  chemical  synthesis  or analysis,  whereby repulsive field conductors  are  arranged around  bead electrodes used for selectively attracting  and retaining beads.  Problems of bead control are addressed  by adding  repulsive fields to help guide and direct  beads  to desired  or designated bead collection zones.  The repulsive electrodes create non-uniform electric fields that  control, focus,  and  deflect charged beads in the  vicinity  of  the bead   collection  zone,  helping  prevent   multiple   bead retention  at  intended bead collection zones.   For  better bead  control,  and  allowing  manipulation  of  beads  with higher  charge/mass  ratios,  dielectric  material  may   be positioned  around the bead electrode and between  the  bead electrode and the repulsive field conductor.  Multiple  bead electrodes  may  be  provided  to  form  two  or  more  bead collection  zones,  and  these may be selectively  addressed and  controlled  (e.g., x-y addressing) for  individual  and selective  control  of the bead collection  zones.   Methods and   applied  voltages  are  given  for  using   the   bead transporter chuck to transport and dispense beads.
Patent NZ-505997-A (NZ)
Title: Expand and genetically modified populations of human hematopoietic stem cells
Inventor: MURRAY LESLEY JEAN
IPC: A61K35/12
Filed: 1999-01-29
Abstract: A method for genetically modifying human hematopoietic stem cells comprises, contacting a vector comprising a polynucleotide sequence encoding a heterologous gene with a population of hematopoietic stem cells cultured with fibronectin and in the presence of an effective amount of mpl ligand and a lft3 ligand and then obtaining the modified cells Each ligand is provided in a concentration of about 0.1 ng/mL to about 500 ng/mL. The vector is selected from reteroviral vectors, adenoviral vectors and adeno-associated viral vectors. Also described is method for transducing mammalian CD34+ hematopoietic cells which includes a subpopulation of hematopoietic stem cells. The method comprises culturing the cells in the presence of fibronectin and with the cytokines TPO, FL and IL-6 each individually provided in the range of about 0.1 ng/mL to about 500 ng/mL. The cultured cells are then infected with a reteroviral vector including a polynucleotide sequence encoding a heterologous gene and the transduced cells where the gene is expressed.
Patent NZ-506865-A (NZ)
Title: A drug delivery system formulation for fat soluble drugs such as vitamins A, D & K
Inventor: HAY YUEN KAH
IPC: A61K9/40
Filed: 2000-09-11
Abstract: Described is an oral composition which may be formulated to self-emulsify under gentle agitation and in the presence of an aqueous medium.  The composition comprises: (i) a fat-soluble drug selected from tocotrienols, tocopherols, and vitamins A, D, K and b-carotene; (ii) palm olein or soybean oil; and (iii) a surfactant system which is a combination of caprylocaproyl macrogolglycerides EP (Labrasol) and poloxyethylene 20 sorbitan monoleate (Tween 80).
Patent NZ-507796-A (NZ)
Title: Stable carbanilide composition
Inventor: GU BEN
IPC: A61K31/17
Filed: 1999-04-29
Abstract: A liquid composition comprises a) an anti-bacterial aromatic carbanilide; b) a water soluble polyethylene glycol of molecular weight of at least 200 with the quantity of component b) sufficient to solubilize the carbanilide and c) a fragrance useful in a personal cleansing composition in quantities sufficient to at least (i) prolong the solubilization of component a) in component b) and/or (ii) inhibit the decomposition of the carbanilide.
Patent NZ-508814-A (NZ)
Title: A method of measuring the diameter of underground columns made by jet grouting
Inventor: FRAPPIN PIERRE
IPC: E21B47/08
Filed: 2000-12-12
Abstract: A method of measuring the diameter of columns (32) in the ground created by jet grouting comprising the steps of: I) Drilling a cylindrical reference borehole (12) having a length (L) substantially the same length as the required column (32), II) Inserting a tubular measuring instrument (16), comprising a plurality of probes (18), to measure and record the resistivity of the ground (10) at different depths. III) Inserting the tubular measuring instrument (16) into a cylindrical hole (14) made in the jet grouted column (32) and comparing the resistivity recorded with that of the reference borehole (12) to determine the diameter of the columns (32) at the respective depths.
Patent NZ-516533-A (NZ)
Title: Use  of  neutrophil inhibitors in the  manufacture  of medicaments to inhibit inflammatory responses and neutrophil activity
Inventor: MOYLE MATTHEW
IPC: A61K38/17
Filed: 1993-05-11
Abstract: Use  of a mature Neutrophil Inhibitor Factor  (NIF1FL) amino  acid  sequence in the manufacture of a medicament  to treat   a  pathological  condition  in  a  mammal  that   is ameliorated  by  inhibition of neutrophil activity.   It  is also   useful  for  preventing  or  decreasing  inflammatory responses in mammals.  Pathological conditions that  may  be treated   comprise   acute  chronic   allograft   rejection, autoimmune  diabetes, rheumatoid arthritis and  inflammatory bowel disease among others. Neutrophil  Inhibitor Factor may be obtained from  parasitic worms.
Patent NZ-519393-A (NZ)
Title: Plant growth container fabricated from cuspated sheet
Inventor: LAWTON PETER
IPC: A01G9/02
Filed: 2000-11-13
Abstract: A panel (10) for use as a side wall of a plant growth container is disclosed. In one embodiment the panel (10) comprises an elongate cuspated sheet (11) having apertures formed in at least some of the outwardly projecting cusps to facilitate air root pruning of the root structure of a plant grown within the container. The sheet (11) includes a non-cuspated edge section (12), the non-cuspated edge section (12) being co-operable with a complementary edge section (13) of the same sheet (11) or of an adjacent sheet. The co-operable edge sections (12, 13) form a guideway for holding means (32), the holding means (32) passing along the guideway to releasably hold the edge sections (12, 13) in use form a side wall of the container. A plant growth container having at least one panel (10) as described is also disclosed.
Patent NZ-519939-A (NZ)
Title: Substituted piperidines, medicaments containing these compounds, and methods for the production thereof
Inventor: RUDOLF KLAUS
IPC: C07D405/14
Filed: 2000-12-22
Abstract: Disclosed is a substituted piperidine of general formula (I) wherein: R, R1 - R4 are as defined, and One of groups A1 and A2 denotes a hydrogen atom and the other denotes an amino, [1,4]bipiperidinyl-1'-yl or an alkyl amino group or the group represented by formula (II). Compounds of formula (I) exhibit CGRP-antagonistic properties and show affinity for the CGRP receptor.
Patent NZ-522635-A (NZ)
Title: A method and apparatus for temperature measurement of frozen organic matter using electromagnetic radiation
Inventor: PETCH PHILIP EDWARD
IPC: G01N33/12
Filed: 2002-12-17
Abstract: An apparatus or measuring the transmission or attenuation of electromagnetic radiation through an object (6), the apparatus includes an electromagnetic radiation emitter (2) and detector (3), characterized in that to perform transmission/attenuation measurements, the apparatus is configurable such that the emitter (2) is positioned immediately adjacent the surface of the object and the detector (3) is positioned on an opposing side of the object such that the detector solely, or at least substantially receives electromagnetic radiation transmitted through the object from the emitter (2). The object (6) includes any substance, material, or organic matter containing moisture and/or any other substance where the transmittivity of electromagnetic radiation energy changes measurably with temperature. The apparatus further includes a drive apparatus (7) capable of reversibly placing the emitter immediately adjacent or in contact with a surface of the object. The drive apparatus (7) is pneumatic, hydraulic, or electro-mechanical operated linear actuator.